Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-21-013107
Filing Date
2021-04-16
Accepted
2021-04-16 16:34:41
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A nc10020263x2_defa14a.htm DEFA14A 39597
2 nc10020263x2_nc1.jpg GRAPHIC 159771
3 nc10020263x2_nc2.jpg GRAPHIC 124584
  Complete submission text file 0001140361-21-013107.txt   432439
Mailing Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34207 | Film No.: 21831940
SIC: 2834 Pharmaceutical Preparations